- Investing Ideas
- Hong Kong Healthcare Undervalued based on future growth
Hong Kong Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
Sinopharm Group
Market Cap: HK$50.4b
Engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China.
1099
HK$15.91
7D
2.1%
1Y
-13.4%
Hygeia Healthcare Holdings
Market Cap: HK$5.7b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$9.17
7D
3.7%
1Y
-39.9%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$5.7b
Engages in the research, development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China and internationally.
1858
HK$8.53
7D
-2.8%
1Y
-30.4%
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$3.5b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices.
2291
HK$10.20
7D
13.3%
1Y
-49.4%
Chaoju Eye Care Holdings
Market Cap: HK$1.6b
Owns and operates a network of ophthalmic hospitals and centers in the People’s Republic of China.
2219
HK$2.45
7D
-1.6%
1Y
-14.0%
Sisram Medical
Market Cap: HK$1.1b
Engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America.
1696
HK$2.27
7D
1.3%
1Y
-47.8%
Yonghe Medical Group
Market Cap: HK$1.1b
Provides hair-related healthcare services in China.
2279
HK$2.06
7D
1.5%
1Y
24.8%